Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking strategy to diabetes management. These innovative drugs function by mimicking the natural actions of GLP-1, a hormone released by the gut https://mysitesname.com/story10669463/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes